Tutt, A., Tovey, H., Cheang, M., Kernaghan, S., Kilburn, L., Gazinska, P., Owen, J., Abraham, J., Barrett, S., Barrett-Lee, P., Brown, R., Chan, S., Dowsett, M., Flanagan, J., Fox, L., Grigoriadis, A., Gutin, A., Harper-Wynne, C., Hatton, M., Hoadley, K., Parikh, J., Parker, P., Perou, C., Roylance, R., Shah, V., Shaw, A., Smith, I., Timms, K., Wardley, A., Wilson, G., Gillett, C., Lanchbury, J., Ashworth, A., Rahman, N., Harries, M., Ellis, P., Pinder, S., & Bliss, J. (2018). carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial. Nature medicine, 24, 628–637. http://access.bl.uk/ark:/81055/vdc_100079359320.0x000108